News Moberg Pharma AB

Equities

MOB

SE0020353928

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 04:33:49 2026-06-08 am EDT			5-day change	1st Jan Change
10.33 ^SEK	+3.71%		+4.73%	+1.27%

03:40am	Moberg Pharma Enters New Commercialization Deal for Nail Fungus Drug in China	MT
02:11am	Moberg Pharma expands partnership with Karo Healthcare to China	FW

All News

Mentions Relevance

03:40am	Moberg Pharma Enters New Commercialization Deal for Nail Fungus Drug in China	MT
02:11am	Moberg Pharma expands partnership with Karo Healthcare to China	FW
02:01am	Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China	AQ
May. 22	Moberg Pharma's newly elected Chairman Lars Johansson makes maiden share purchase	FW
May. 21	Bulletin from Moberg Pharma's AGM on May 21[st], 2026	AQ
May. 21	Moberg Pharma AB Approves the Election of Board Members	CI
May. 13	Moberg Pharma (Q1 Review): APAC Expansion strengthens long-term growth case	AQ
May. 12	Moberg Pharma reports revenue growth and narrowed losses	FW
May. 12	Moberg Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 24	Moberg Pharma, Karo Healthcare expand collaboration	RE
Apr. 24	Moberg Pharma, Karo Healthcare Add New Markets in Expanded Licensing Deal for Nail Fungus Drug	MT
Apr. 24	Moberg Pharma expands agreement with Karo Healthcare to bring MOB-015 to new markets	FW
Apr. 24	Moberg Pharma expands partnership with Karo Healthcare	FW
Apr. 24	Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to Australia, New Zealand, South Korea and Taiwan	AQ
Apr. 24	Moberg Pharma AB and Karo Healthcare Enter Licensing Agreement for MOB-015/Terclara in Australia, New Zealand, South Korea and Taiwan	CI
Apr. 20	Moberg Pharma : Annual report 2025 (Moberg AR 2025 ENG Final)	PU
Apr. 17	Moberg Pharma proposes Lars Johansson as new Chairman	FW
Apr. 17	Moberg Pharma : Notice of AGM (Moberg Pharma Notice of AGM 2026 FINAL)	PU
Apr. 17	Moberg Pharma : The Board of Directors proposal for resolution on the implementation of a long-term incentive program (Moberg Pharma The Board of Directors proposal for resolution on the implementation of a long term incentive program (ENG))	PU
Apr. 17	Notice of Annual General Meeting in Moberg Pharma AB (publ)	AQ
Apr. 17	Moberg Pharma Annual Report 2025	AQ
Apr. 17	Moberg Pharma AB Announces Board Members Not Standing for Re-Elections	CI
Mar. 13	Moberg Pharma Secures Additional Terbinafine Supplier for Nail Fungus Drug	MT
Mar. 13	Moberg Pharma AB Secures Additional Terbinafine Supplier For Mob-015	CI
Mar. 13	Moberg Pharma secures additional terbinafine supplier	FW